市場調查報告書
商品編碼
1081056

體外式薄膜型人工肺市場:現狀分析與預測(2021年∼2027年)

Extracorporeal Membrane Oxygenation Machine Market: Current Analysis and Forecast (2021-2027)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 248 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

體外式薄膜型人工肺的市場規模,在預測期間(2021年∼2027年)時以約5%的年複合成長率擴大。再加上WHO心臟血管手術增加,冠狀動脈疾病(CAD)和心臟衰竭,重症急性呼吸窘迫症候群(ARDS)等的心臟、肺部疾病的發生率上升,預計今後數年牽引體外式薄膜型人工肺市場。

本報告提供體外式薄膜型人工肺市場相關調查,市場現狀,以及各種模式,各用途,各零件,各終端用戶,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 市場簡介

第2章 調查手法或假設

第3章 市場摘要

第4章 摘要整理

第5章 體外式薄膜型人工肺(ECMO)市場上COVID-19影響

第6章 體外式薄膜型人工肺(ECMO)市場收益(10億美元),2019年∼2027年

第7章 各種模式的市場洞察

  • VA(靜脈→動脈)
  • VV(靜脈→靜脈)
  • AV(動脈→靜脈)

第8章 各用途的市場洞察

  • 心臟
  • 呼吸系統
  • 體外心肺甦醒法(ECPR)

第9章 各零件的市場洞察

  • 幫浦
  • 氧供給器
  • 控制器
  • 導管
  • 配件

第10章 各終端用戶的市場洞察

  • 醫院,診所
  • 門診病人手術中心
  • 其他

第11章 各地區的市場洞察

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第12章 體外式薄膜型人工肺(ECMO)的市場動態

  • 市場促進因素
  • 市場課題
  • 影響分析

第13章 體外式薄膜型人工肺(ECMO)市場機會

第14章 體外式薄膜型人工肺(ECMO)市場趨勢

第15章 相關法規

第16章 需求面與供給方面分析

  • 需求面分析
  • 供給方面分析

第17章 競爭模式

  • 競爭情形
    • 波特的五力分析

第18章 企業概要

  • Fresenius Medical Care AG & Co. KGaA
  • Getinge Group
  • Medtronic plc
  • Terumo Cardiovascular Systems Corporation
  • Nipro Corporation
  • Xenios AG
  • Alung Technologies, Inc.
  • Livanova plc
  • Eurosets SRL
  • Abiomed

第19章 免責聲明

目錄
Product Code: UMHE21798

ECMO Machine Market is anticipated to display a CAGR of around 5% over the forecast period (2021-2027). Moreover, according to the World Health Organization The increase in the number of Cardiovascular surgeries, as well as the rising incidences of Heart and Lung diseases such as coronary artery diseases (CAD) and cardiac failure or severe acute respiratory distress syndrome (ARDS), are expected to drive the market for extracorporeal membrane oxygenation machine market in the coming years. according to WHO, Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Furthermore, around 17.9 million people died because of CVDs in 2019, and 85% of these deaths were due to Heart attack. In addition, the growing geriatric elderly population in developing countries coupled with the increase in the prevalence of chronic inflammatory lung diseases is further expected to create the demand the ECMO machine market. Moreover, the adoption of minimally invasive surgeries across geographies is another crucial factor driving the market.

Insights Presented in the Report

"Amongst modality, Arterial-venous segment held significant market share in 2020"

Based on the modality, the market bifurcated into veno-arterial, veno-venous, arterial-venous. Among these segments Arterial-venous (VA-ECMO) is projected to attain the largest market share in 2020 and expected to increase with a healthy CAGR in forecast period. The use of Arterial-venous (VA-ECMO) promotes gas exchange, especially the removal of carbon dioxide, by pumping blood into the circulatory system using the patient's arterial pressure.

Arterial-Venous provides removal of Carbon dioxide (ECCO2 R) from the body, by using patients own Arterial pressure to pump the blood. Furthermore, advantages linked with this segment area such as better medical evaluation, and effective dynamic range are contributing to its market expansion. Using ECMO machines, various steps are included in the treatment process, such as surgeries, post-operative follow-ups, and the current condition of the patient's heart & lungs. Thus, due to the rising demand for early diagnosis and effective treatment, is further contributing to the category's growth. ECMO's accuracy, and speed encourages its adoption, and it is expected to grow in popularity in the future.

"Amongst Application, Respiratory acquires largest market share"

Based on the application, the market is segmented into cardiac, respiratory, and extracorporeal cardiopulmonary resuscitation (ECPR). Of these three, chronic respiratory diseases acquired the largest share of the market in 2020. The growth of the segment is mainly due to the rising prevalence of chronic diseases, a number of cardiac surgeries entwined with the growing aging population around the world, which is further expected to fuel the growth of ECMO machines.

According to data published by the Extracorporeal Life Support Organization (ELSO), in 2015, over 2,600 patients in the U.S. with respiratory diseases received ECMO therapy. Moreover, ECMO has been used on 151,683 patients through 2020, including 30,743 children, 45,205 neonates, and 75,735 adults. Furthermore, rising alcohol consumption and smoking coupled with a sedentary lifestyle are growing the worldwide burden of cardiac and respiration illnesses in adults.

"Amongst End-User, Hospitals & Clinics acquires largest market share"

Based on end-user, the market is segmented into hospitals & clinics, ambulatory surgery centers, and others. Among these segments, ECMO machine market is in high demand in hospitals & Clinics because it provides advanced tools to orthopedic surgeons to improve visualization of complex cases, improve medical care efficiency, reduce time and healthcare costs, improve data management, and many other benefits. In addition to this, a rise in the number of healthcare facilities across countries coupled with the surging investment in the research and development by the hospitals are resulting in the growth of the extracorporeal membrane oxygenation machine market. Furthermore, the government across countries are investing in the healthcare industry for advancements and technological upgradation. Moreover, rising patient footfall in hospitals owing to ease of accessibility to the majority of healthcare services in one place is likely to boost the segment growth.

"North America will Dominate the Market During the Forecast Period"

For a better understanding of the market adoption of ECMO machines, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific), and Rest of World. In 2020, the North American region held the highest market share in the global ECMO Machine market.

Some of the major players operating in the market are Fresenius Medical Care AG & Co. KGaA, Getinge Group, Medtronic plc, Terumo Cardiovascular Systems Corporation, Nipro Corporation, Xenios AG, Alung Technologies, Inc., Livanova plc, Eurosets S.R.L., Abiomed.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

The study comprehensively covers the market across different segments

Deep dive regional level analysis of the industry

Customization Options:

The ECMO Machine Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Limitation
  • 1.3. Stakeholders
  • 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Extracorporeal Membrane Oxygenation (ECMO) Machine Market
  • 2.2. Research Methodology of the Extracorporeal Membrane Oxygenation (ECMO) Machine Market
  • 2.3. Forecasting Method
  • 2.4. Respondent Profile
  • 2.5. Main Objective of the Extracorporeal Membrane Oxygenation (ECMO) Machine Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) MACHINE MARKET COVID-19 IMPACT

6 EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) MACHINE MARKET REVENUE (USD BN), 2019-2027F

7 MARKET INSIGHTS BY MODALITY

  • 7.1. Veno-Arterial
  • 7.2. Veno-Venous
  • 7.3. Arterio-Venous

8 MARKET INSIGHTS BY APPLICATION

  • 8.1. Cardiac
  • 8.2. Respiratory
  • 8.3. Extracorporeal cardiopulmonary resuscitation (ECPR)

9 MARKET INSIGHTS BY COMPONENT

  • 9.1. Pumps
  • 9.2. Oxygenators
  • 9.3. Controllers
  • 9.4. Cannula
  • 9.5. Accessories

10 MARKET INSIGHTS BY END-USER

  • 10.1. Hospitals & Clinics
  • 10.2. Ambulatory Surgery centres
  • 10.3. Others

11 MARKET INSIGHTS BY REGION

  • 11.1. North America
    • 11.1.1. United States
    • 11.1.2. Canada
    • 11.1.3. Rest of North America
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. UK
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. South Korea
    • 11.3.6. Rest of Asia-Pacific
  • 11.4. Rest of World

12 EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) MACHINE SOFTWAREMARKET DYNAMICS

  • 12.1. Market Drivers
  • 12.2. Market Challenges
  • 12.3. Impact Analysis

13 EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) MACHINE MARKET OPPORTUNITIES

14 EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) MACHINE MARKET TRENDS

15 LEGAL & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY SIDE ANALYSIS

  • 16.1. Demand Side Analysis
  • 16.2. Supply Side Analysis

17 COMPETITIVE SCENARIO

  • 17.1. Competitive Landscape
    • 17.1.1. Porter's Five Forces Analysis

18 COMPANY PROFILED

  • 18.1. Fresenius Medical Care AG & Co. KGaA
  • 18.2. Getinge Group
  • 18.3. Medtronic plc
  • 18.4. Terumo Cardiovascular Systems Corporation
  • 18.5. Nipro Corporation
  • 18.6. Xenios AG
  • 18.7. Alung Technologies, Inc.
  • 18.8. Livanova plc
  • 18.9. Eurosets S.R.L.
  • 18.10. Abiomed

19 DISCLAIMER